Impact of Electron Beam Tomography, with or Without Case Management, on Motivation, Behavioral Change, and Cardiovascular Risk Profile: A Randomized Controlled Trial

JAMA

Volumn 289, Issue 17, 2003, Pages 2215-2223

  O'Malley, Patrick G ^a,b   Feuerstein, Irwin M ^a,b   Taylor, Allen J ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARMY; ARTERY CALCIFICATION; ARTICLE; BEHAVIOR; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTRON BEAM TOMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT CARE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCREENING; UNITED STATES; CARDIOVASCULAR DISEASE; CASE MANAGEMENT; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; HEALTH BEHAVIOR; MASS SCREENING; MOTIVATION; MULTIVARIATE ANALYSIS; RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; CARDIOVASCULAR DISEASES; CASE MANAGEMENT; CORONARY ARTERIOSCLEROSIS; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; MASS SCREENING; MOTIVATION; MULTIVARIATE ANALYSIS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RISK ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037900014     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.17.2215     Document Type: Article

References (49)

1. Grundy SM, Balady GJ, Criqui MH, et al. Primary prevention of coronary heart disease: guidance from Framingham. Circulation. 1998;97:1876-1887.
2. Stamler J, Stamler R, Neaton JD, et al. Low risk factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA. 1999;282:2012-2018.
3. Robertson I, Phillips A, Mant D, et al. Motivational effect of cholesterol measurement in general practice health checks. Br J Gen Pract. 1992;42:469-472.
4. Elton PJ, Ryman A, Hammer M, Page F. Randomised controlled trial in northern England of the effect of a person knowing their own serum cholesterol concentration. J Epidemiol Community Health. 1994;48:22-25.
5. Barratt A, Reznik R, Irwig L, et al. Work-site cholesterol screening and dietary intervention: the Staff Healthy Heart Project. Am J Public Health. 1994;84:779-782.
6. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ. 1994;308:313-320.
7. Murray DM, Luepker RV, Pirie PL, et al. Systematic risk factor screening and education: a community-wide approach to prevention of coronary heart disease. Prev Med. 1986;15:661-672.
8. Engberg M, Christensen B, Karlsmose B, Lous J, Lauritzen T. General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up. J Fam Pract. 2002;51:546-552.
9. Havas S, Reisman J, Hsu L, Koumjian, L. Does cholesterol screening result in negative labeling effects? results of the Massachusetts Model Systems for Blood Cholesterol Screening Project. Arch Intern Med. 1991;151:113-119.
10. Feldman W. How serious are the adverse effects of screening? J Gen Intern Med. 1990;5(suppl):S50-S53.
11. Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making. 1993;13:89-102.
12. Murray CJ, Lopez AD, eds. The Global Burden of Disease and Global Health Statistics. Cambridge, Mass: Harvard University Press; 1996.
13. Hoeg JM. Evaluating coronary heart disease risk. JAMA. 1997;277:1387-1390.
14. O'Malley PG, Taylor AJ, Jackson JL, Doherty T, Detrano R. Prognostic value of coronary electron beam computed tomography for coronary heart disease events in asymptomatic populations. Am J Cardiol. 2000;85:945-948.
15. Wong ND, Detrano RC, Diamond G, et al. Does coronary artery screening by electron beam computed tomography motivate potentially beneficial lifestyle behaviors? Am J Cardiol. 1996;78:1220-1223.
16. Moher D, Schulz KF, Altman DG, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med. 2001;134:657-662.
17. O'Malley PG, Taylor AJ, Gibbons RV, et al. Rationale and design of the Prospective Army Coronary Calcium (PACC) study: utility of electron beam computed tomography as an screening test for coronary artery disease and as an intervention for risk factor modification among young, asymptomatic, active-duty United States Army personnel. Am Heart J. 1999;137:932-941.
18. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med. 1977;31:42-48.
19. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121(1 pt 2):293-298.
20. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short form health survey (SF-36), II: psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247-263.
21. Taylor JA. A personality scale of manifest anxiety. J Abnorm Soc Psychol. 1953;48:285-290.
22. Spitzer RL, Kroenke K, Williams JB, and the Patient Health Questionnaire Primary Care Study Group. Validation and utility of a self-report version of PRIME-MD-the PHQ Primary Care Study. JAMA. 1999;282:1737-1744.
23. DiClemente CC, Prochaska JO, Fairhurst SK. The process of smoking cessation: an analysis of the precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol. 1991;59:295-304.
24. Biener L, Abrams DB. The contemplation ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol. 1991;10:360-365.
25. Baecke JA, Burema HJ, Fruters ER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36:936-942.
26. Block G, Hartman AM, Naughton D. A reduced dietary questionnaire: development and validation. Epidemiology. 1990;1:58-64.
27. Cook WW, Medley DM. Proposed hostility and pharisaic-virtue scales for the MMPI. J Appl Psychol. 1954;38:414-418.
28. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte MJ, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827-832.
29. Shields JP, Mielke CH, Watson P, Viren F. Comparison of 10, 20, and 40 level electron beam computed tomography studies for coronary calcium. Am J Card Imaging. 1996;10:235-238.
30. Wang S, Detrano RC, Secci A, et al. Detection of coronary calcification with electron beam computed tomography: evaluation of interexamination reproducibility and comparison of three image acquisition protocols. Am Heart J. 1996;132:550-558.
31. Janowitz WR, Agatston AS, Kaplan G, Viamonte M. Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. Am J Cardiol 1993;72:247.
32. Rumberger JA, Sheedy PF, Breen JF, Schwartz RS. Electron beam computed tomographic coronary calcium score cutpoints and severity of associated angiographic lumen stenosis. J Am Coll CardioL 1997;29:1542-1548.
33. Kajinami K, Seki H, Takekoshi N, Mabuchi H. Coronary calcification and coronary atherosclerosis: site by site comparative morphologic study of electron beam computed tomography and coronary angiography. J Am Coll Cardiol. 1997;29:1549-1556.
34. Schmermund A, Baumgart D, Gorge G, et al. Coronary artery calcium in acute coronary syndromes. Circulation. 1997;96:1461-1469.
35. Stevens VJ, Glasgow RE, Hollis JF, Lichtenstein E, Vogt TM. A smoking-cessation intervention for hospital patients. Med Care. 1993;31:65-72.
36. Dornelas EA, Sampson RA, Gray JF, Waters D, Thompson PD. A randomized controlled trial of smoking cessation counseling after myocardial infarction. Prev Med. 2000;30:261-268.
37. DeBusk RF, Miller NH, Superko HR, et al. A case management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med. 1994;120:721-729.
38. Haskell WL, Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. Circulation. 1994;89:975-990.
39. Silverman SL, Greenwald M, Klein RA, Drinkwater BL. Effect of bone density information about hormone replacement therapy: a randomized trial. Obstet Gynecol. 1997;89:321-325.
40. Torgerson DJ, Thomas RE, Campbell MK, Reid DM. Randomized trial of osteoporosis screening. Arch Intern Med. 1997;157:2121-2125.
41. Shaw C, Abrams K, Marteau TM. The psychological impact of predicting individuals' risk of illness: a systematic review. Soc Sci Med. 1999;49:1571-1598.
42. Elgin E, O'Malley PG, Feuerstein I, Taylor AT. Frequency and severity of "incidentalomas" encountered during electron beam computed tomography for coronary calcium in middle-aged Army personnel. Am J Cardiol. 2002;90:543-545.
43. Horton KM, Post WS, Blumenthal RS, Fishman EK. Prevalence of significant noncardiac findings on electron-beam computed tomography coronary artery calcium screening examinations. Circulation. 2002;106:532-534.
44. Ebrahim S, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 2000; issue 2.
45. Greenland P, Smith SC, Grundy SM. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation. 2001;104:1863.
46. Park R, Detrano R, Xiang M, et al. Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals. Circulation. 2002;106:2073-2077.
47. Shaw LJ, Callister TQ, Schisterman E, Berman DS, Raggi P. Prognostic value of cardiac risk factors and coronary artery calcium screening for all cause mortality. Radiology. In press.
48. Taylor AT, O'Malley PG. Self-referral of patients for electron-beam computed tomography to screen for coronary artery disease. N Engl J Med. 1998;339:2018-2020.
49. Lee TH, Brennan TA. Direct-to-consumer marketing of high technology screening tests. N Engl J Med. 2002;346:529-531.